AZN icon

AstraZeneca

945 hedge funds and large institutions have $29.4B invested in AstraZeneca in 2021 Q4 according to their latest regulatory filings, with 149 funds opening new positions, 267 increasing their positions, 326 reducing their positions, and 87 closing their positions.

Holders
945
Holders Change
+44
Holders Change %
+4.88%
% of All Funds
14.59%
Holding in Top 10
13
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-23.53%
% of All Funds
0.2%
New
149
Increased
267
Reduced
326
Closed
87
Calls
$713M
Puts
$509M
Net Calls
+$204M
Net Calls Change
-$95.6M
Name Market Value Shares Shares
Change
Shares
Change %
Russell Investments Group
51
Russell Investments Group
United Kingdom
$71.7M 1,230,844 -410,659 -25%
Citadel Advisors
52
Citadel Advisors
Florida
$68.5M 1,176,429 +206,057 +21%
Federated Hermes
53
Federated Hermes
Pennsylvania
$68.5M 1,175,935 +277,619 +31%
Jane Street
54
Jane Street
New York
$68.5M 1,175,509 -20,897 -2%
SI
55
Scharf Investments
California
$63M 1,081,981 +115,951 +12%
First Trust Advisors
56
First Trust Advisors
Illinois
$62.3M 1,068,730 +61,772 +6%
CS
57
Candriam SCA
Luxembourg
$61.8M 1,061,210 +32,777 +3%
HJGA
58
Hardman Johnston Global Advisors
Connecticut
$61.8M 1,061,109 -63,781 -6%
TIM
59
Thornburg Investment Management
New Mexico
$61.8M 1,060,894 +95,371 +10%
SFM
60
Sphera Funds Management
Israel
$61.5M 1,055,467 -236,200 -18%
UBS Group
61
UBS Group
Switzerland
$56.9M 977,174 -15,311 -2%
EP
62
Eversept Partners
New York
$55.3M 949,224 +58,416 +7%
1832 Asset Management
63
1832 Asset Management
Ontario, Canada
$52.3M 893,259 +253,840 +40%
Two Sigma Investments
64
Two Sigma Investments
New York
$51.3M 880,505 +577,756 +191%
Envestnet Asset Management
65
Envestnet Asset Management
Illinois
$50M 858,353 +108,105 +14%
Ensign Peak Advisors
66
Ensign Peak Advisors
Utah
$49.9M 856,824 +686,697 +404%
Optiver Holding
67
Optiver Holding
Netherlands
$49.8M 854,075 +854,075 New
Susquehanna International Group
68
Susquehanna International Group
Pennsylvania
$49.5M 850,376 -2,030,621 -70%
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
$47.8M 820,943 -356,161 -30%
Dodge & Cox
70
Dodge & Cox
California
$47.6M 817,895 -25,970 -3%
Arrowstreet Capital
71
Arrowstreet Capital
Massachusetts
$47M 807,208 +807,208 New
TCM
72
Tekla Capital Management
Massachusetts
$45.9M 787,485 -25,442 -3%
PHS
73
PFM Health Sciences
California
$45.8M 785,748
Macquarie Group
74
Macquarie Group
Australia
$45.4M 778,980 -37,116 -5%
Adage Capital Partners
75
Adage Capital Partners
Massachusetts
$43.7M 750,000 -2,063,663 -73%